Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
- PMID: 27671162
- DOI: 10.1016/j.jaci.2016.07.013
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
Abstract
Background: Atopic dermatitis (AD) affects 15% to 25% of children and 4% to 7% of adults. Paradigm-shifting discoveries about AD have been based on adult biomarkers, reflecting decades of disease activity, although 85% of cases begin by 5 years. Blood phenotyping shows only TH2 skewing in patients with early-onset pediatric AD, but alterations in early pediatric skin lesions are unknown, limiting advancement of targeted therapies.
Objective: We sought to characterize the early pediatric AD skin phenotype and its differences from pediatric control subjects and adults with AD.
Methods: Using immunohistochemistry and quantitative real-time PCR, we assessed biopsy specimens from 19 children with AD younger than 5 years within 6 months of disease onset in comparison with adults with AD or psoriasis and pediatric and adult control subjects.
Results: In lesional skin children showed comparable or greater epidermal hyperplasia (thickness and keratin 16) and cellular infiltration (CD3+, CD11c+, and FcεRI+) than adults with AD. Similar to adults, strong activation of the TH2 (IL-13, IL-31, and CCL17) and TH22 (IL-22 and S100As) axes and some TH1 skewing (IFN-γ and CXCL10) were present. Children showed significantly higher induction of TH17-related cytokines and antimicrobials (IL-17A, IL-19, CCL20, LL37, and peptidase inhibitor 3/elafin), TH9/IL-9, IL-33, and innate markers (IL-8) than adults (P < .02). Despite the characteristic downregulation in adult patients with AD, filaggrin expression was similar in children with AD and healthy children. Nonlesional skin in pediatric patients with AD showed higher levels of inflammation (particularly IL-17A and the related molecules IL-19 and LL37) and epidermal proliferation (keratin 16 and S100As) markers (P < .001).
Conclusion: The skin phenotype of new-onset pediatric AD is substantially different from that of adult AD. Although excess TH2 activation characterizes both, TH9 and TH17 are highly activated at disease initiation. Increases in IL-19 levels might link TH2 and TH17 activation.
Keywords: Atopic dermatitis; IL-17; IL-19; T(H)17; T(H)2; T(H)9; adult; antimicrobials; pediatric; skin.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults.J Allergy Clin Immunol. 2021 Jul;148(1):148-163. doi: 10.1016/j.jaci.2021.01.001. Epub 2021 Jan 13. J Allergy Clin Immunol. 2021. PMID: 33453290 Free PMC article.
-
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.J Allergy Clin Immunol. 2015 Nov;136(5):1254-64. doi: 10.1016/j.jaci.2015.08.015. Epub 2015 Oct 1. J Allergy Clin Immunol. 2015. PMID: 26428954
-
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.J Allergy Clin Immunol. 2013 Aug;132(2):361-70. doi: 10.1016/j.jaci.2013.04.046. Epub 2013 Jun 15. J Allergy Clin Immunol. 2013. PMID: 23777851 Free PMC article.
-
Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?Curr Opin Immunol. 2017 Oct;48:68-73. doi: 10.1016/j.coi.2017.08.008. Epub 2017 Sep 1. Curr Opin Immunol. 2017. PMID: 28869867 Review.
-
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.J Allergy Clin Immunol. 2017 Apr;139(4S):S65-S76. doi: 10.1016/j.jaci.2017.01.011. J Allergy Clin Immunol. 2017. PMID: 28390479 Free PMC article. Review.
Cited by
-
FABP5 as a possible biomarker in atopic march: FABP5-induced Th17 polarization, both in mouse model and human samples.EBioMedicine. 2020 Aug;58:102879. doi: 10.1016/j.ebiom.2020.102879. Epub 2020 Jul 22. EBioMedicine. 2020. PMID: 32711257 Free PMC article.
-
Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.Medicine (Baltimore). 2020 Sep 18;99(38):e22043. doi: 10.1097/MD.0000000000022043. Medicine (Baltimore). 2020. PMID: 32957324 Free PMC article.
-
Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication.Dermatol Ther. 2022 Dec;35(12):e15901. doi: 10.1111/dth.15901. Epub 2022 Oct 13. Dermatol Ther. 2022. PMID: 36200594 Free PMC article. Review.
-
Epidermal Barrier Function and Skin Homeostasis in Atopic Dermatitis: The Impact of Age.Life (Basel). 2022 Jan 17;12(1):132. doi: 10.3390/life12010132. Life (Basel). 2022. PMID: 35054525 Free PMC article.
-
Revisiting Therapies for Atopic Dermatitis that Failed Clinical Trials.Clin Drug Investig. 2020 May;40(5):421-431. doi: 10.1007/s40261-020-00905-7. Clin Drug Investig. 2020. PMID: 32172523 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials